RespireRx Pharmaceuticals (RSPI) Short Interest Ratio & Short Volume

Short interest is the volume of RespireRx Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 83,700 shares of RSPI short. Learn More on RespireRx Pharmaceuticals' current short interest.

RespireRx Pharmaceuticals saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 83,700 shares, an increase of 280.5% from the previous total of 22,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to RespireRx Pharmaceuticals: Comera Life Sciences Holdings, Inc. (2.38%), GlobeStar Therapeutics Co. (0.00%), SciSparc Ltd. (4.18%), China SXT Pharmaceuticals, Inc. (2.63%), Aptevo Therapeutics Inc. (16.76%), Evelo Biosciences, Inc. (2.11%), Aditxt, Inc. (8.48%), Sunshine Biopharma, Inc. (29.84%), Nexien BioPharma, Inc. (0.04%), Skinvisible, Inc. (0.05%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

Short selling RSPI is an investing strategy that aims to generate trading profit from RespireRx Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for RespireRx Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RSPI, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RSPI, twice per month. The most recent reporting period available is April, 30 2024.